ESE Form 144 shows $560K planned insider stock sale

Rhea-AI Filing Summary

ESCO Technologies (ESE) insider filed a Form 144 to sell up to 2,498 common shares through Charles Schwab & Co., Inc., with an aggregate market value of $560,451.00. The shares relate to equity compensation awards acquired on three dates in 2024, including 24 shares on 09/10/2024, 848 shares on 10/31/2024, and 1,626 shares on 11/08/2024, all from the issuer as equity compensation. The planned sale is targeted around 11/25/2025 on the NYSE. The filing notes that the person signing represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Common shares outstanding were 25,824,688 at the time referenced, which provides a baseline for comparing the size of the planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2498	560451.00	25824688	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2024	Equity Compensation	Issuer			24	09/10/2024	Equity Compensation
Common	10/31/2024	Equity Compensation	Issuer			848	10/31/2024	Equity Compensation
Common	11/08/2024	Equity Compensation	Issuer			1626	11/08/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ESCO Technologies (ESE) disclose in this Form 144 filing?

The filing shows that an affiliated person intends to sell up to 2,498 common shares of ESCO Technologies stock, with an aggregate market value of $560,451.00, through a broker on the NYSE.

How many ESCO Technologies (ESE) shares are planned to be sold and on what market?

The notice covers a proposed sale of 2,498 common shares of ESCO Technologies on the NYSE, with the broker listed as Charles Schwab & Co., Inc.

When does the ESCO Technologies (ESE) insider expect to sell these shares?

The approximate date of sale in the Form 144 is listed as 11/25/2025, indicating the target timing for the planned transaction.

How were the ESCO Technologies (ESE) shares to be sold originally acquired?

The securities were acquired as equity compensation from the issuer on three dates in 2024: 09/10/2024 (24 shares), 10/31/2024 (848 shares), and 11/08/2024 (1,626 shares).

How large is the planned ESCO Technologies (ESE) sale relative to shares outstanding?

The planned sale covers 2,498 shares, while 25,824,688 common shares were outstanding as of the referenced time, giving context to the transaction’s relative size.

Does the Form 144 for ESCO Technologies (ESE) include any representation about undisclosed adverse information?

Yes. The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about ESCO Technologies’ current or prospective operations that has not been publicly disclosed.